The European Association of Urology (EAU) is committed to raising the level of urological care worldwide. In prostate cancer, although advances in surgical and radiotherapy techniques, as well as the introduction of novel systemic therapies, have been embraced, resulting in incremental improvements in survival outcomes over the past decades, there remains a longstanding reluctance to revisit screening and early diagnosis strategies to reduce the number of men requiring these treatments. As a result, late-stage prostate cancer diagnoses and prostate cancer-related death rates are rising and prostate cancer now ranks as the 2nd biggest cause of cancer-related deaths in men globally.1

X